Company / Interest Expense
Baxter International Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$290.0M
FY2025
5-year range
$207.0M / $508.0M
FY2021-FY2025
Trend
-28.9%
vs FY2024
Sector context
#11 of 44
Health Care
What the data says
Baxter International's interest expense of $290M is higher than 75% of companies in the Health Care sector (FY2025). Interest Expense has fluctuated over the past 10 years, ranging from $85M in FY2019 to $508M in FY2023.
Based on SEC 10-K filings.
$290M in FY2025 with a 5-year CAGR of +13.6%. Top quartile in the Health Care sector.
Improved from $508M to $290M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -11.1%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
-8.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +13.6%, indicating consistent growth.
- In FY2025, interest expense decreased 28.9% year-over-year.
- Ranks #11 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2023.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $290.0M | -28.9% |
| FY2024 | $408.0M | -19.7% |
| FY2023 | $508.0M | +23.0% |
| FY2022 | $413.0M | +99.5% |
| FY2021 | $207.0M | +35.3% |
| FY2020 | $153.0M | +80.0% |
| FY2019 | $85.0M | -8.6% |
| FY2018 | $93.0M | +9.4% |
| FY2017 | $85.0M | -49.1% |
| FY2016 | $167.0M | +14.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026